126 related articles for article (PubMed ID: 9507731)
1. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model.
Blum MG; Collins BJ; Chang AC; Zhang JP; Knaus SA; Pierson RN
Xenotransplantation; 1998 Feb; 5(1):35-43. PubMed ID: 9507731
[TBL] [Abstract][Full Text] [Related]
2. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption.
Zhang JP; Blum MG; Chang AC; Shyr Y; Blair KS; Awwad M; Pierson RN
Xenotransplantation; 1999 Nov; 6(4):249-61. PubMed ID: 10704068
[TBL] [Abstract][Full Text] [Related]
3. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
4. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement.
Pierson RN; Kasper-Konig W; Tew DN; Young VK; Dunning JJ; Horsley J; Carey NR; Wallwork J; White DJ
Transplantation; 1997 Feb; 63(4):594-603. PubMed ID: 9047157
[TBL] [Abstract][Full Text] [Related]
5. Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation.
Tanaka M; Murase N; Ye Q; Miyazaki W; Nomoto M; Miyazawa H; Manez R; Toyama Y; Demetris AJ; Todo S; Starzl TE
Transplantation; 1996 Sep; 62(5):681-8. PubMed ID: 8830837
[TBL] [Abstract][Full Text] [Related]
6. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
[TBL] [Abstract][Full Text] [Related]
7. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175.
Miyagawa S; Shirakura R; Matsumiya G; Fukushima N; Nakata S; Matsuda H; Matsumoto M; Kitamura H; Seya T
Transplantation; 1993 Apr; 55(4):709-13. PubMed ID: 8475539
[TBL] [Abstract][Full Text] [Related]
8. Xenogeneic orthotopic liver transplantation from sheep to pig: delay of rejection by FUT 175 Infusion.
Gridelli B; Gatti S; Andreani P; Donato MF; Bergamaschini L; Berti E; Di Mauro P; Maggioni L; Orsenigo R; Fassati LR; Galmarini D
Transplant Proc; 1996 Apr; 28(2):784-7. PubMed ID: 8623399
[No Abstract] [Full Text] [Related]
9. In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model.
Kobayashi T; Neethling FA; Koren E; Taniguchi S; Ye Y; Niekrasz M; Takagi H; Hancock WW; Cooper DK
Transplant Proc; 1996 Apr; 28(2):604. PubMed ID: 8623297
[No Abstract] [Full Text] [Related]
10. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
[TBL] [Abstract][Full Text] [Related]
11. Hyperacute rejection of mouse lung by human blood: characterization of the model and the role of complement.
Schröder C; Wu GS; Price E; Johnson JE; Pierson RN; Azimzadeh AM
Transplantation; 2003 Sep; 76(5):755-60. PubMed ID: 14501848
[TBL] [Abstract][Full Text] [Related]
12. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
13. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.
Fiane AE; Mollnes TE; Videm V; Hovig T; Høgåsen K; Mellbye OJ; Spruce L; Moore WT; Sahu A; Lambris JD
Xenotransplantation; 1999 Feb; 6(1):52-65. PubMed ID: 10355733
[TBL] [Abstract][Full Text] [Related]
14. Effects of complement suppression on xenograft survival in hyperacute rejection.
Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
[TBL] [Abstract][Full Text] [Related]
15. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.
Yeatman M; Daggett CW; Parker W; Byrne GW; Logan JS; Platt JL; Davis RD
Transplantation; 1998 Apr; 65(8):1084-93. PubMed ID: 9583870
[TBL] [Abstract][Full Text] [Related]
16. Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation.
Kulick DM; Salerno CT; Dalmasso AP; Park SJ; Paz MG; Fodor WL; Bolman RM
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):690-9. PubMed ID: 10733757
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitor nafamostat mesilate attenuates complement activation and improves function of xenografts in a discordant lung perfusion model.
Tagawa T
Xenotransplantation; 2011; 18(6):315-9. PubMed ID: 22168138
[TBL] [Abstract][Full Text] [Related]
18. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
Kim HK; Kim JE; Wi HC; Lee SW; Kim JY; Kang HJ; Kim YT
Xenotransplantation; 2008; 15(4):246-56. PubMed ID: 18957047
[TBL] [Abstract][Full Text] [Related]
19. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.
Collins BJ; Blum MG; Parker RE; Chang AC; Blair KS; Zorn GL; Christman BW; Pierson RN
J Appl Physiol (1985); 2001 Jun; 90(6):2257-68. PubMed ID: 11356791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
